These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Phase II study of docetaxel and ifosfamide combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy with or without paclitaxel. Chen YM; Shih JF; Lee CS; Chen MC; Lin WC; Tsai CM; Perng RP Lung Cancer; 2003 Feb; 39(2):209-14. PubMed ID: 12581575 [TBL] [Abstract][Full Text] [Related]
7. Docetaxel and granulocyte colony-stimulating factor in patients with advanced non-small-cell lung cancer previously treated with platinum-based chemotherapy: a multicenter phase II trial. Alexopoulos K; Kouroussis C; Androulakis N; Papadakis E; Vaslamatzis M; Kakolyris S; Samelis G; Patila E; Vossos A; Samantas E; Georgoulias V Cancer Chemother Pharmacol; 1999; 43(3):257-62. PubMed ID: 9923557 [TBL] [Abstract][Full Text] [Related]
8. Phase II study of docetaxel and cisplatin in advanced non-small-cell lung cancer. Zalcberg J; Millward M; Bishop J; McKeage M; Zimet A; Toner G; Friedlander M; Barter C; Rischin D; Loret C; James R; Bougan N; Berille J J Clin Oncol; 1998 May; 16(5):1948-53. PubMed ID: 9586914 [TBL] [Abstract][Full Text] [Related]
9. Phase II study of docetaxel in the treatment of patients with advanced non-small cell lung cancer in routine daily practice. Mattson K; Bosquee L; Dabouis G; Le Groumellec A; Pujol JL; Marien S; Stupp R; Douillard JY; Brägas B; Berille J; Olivares R; Le Chevalier T Lung Cancer; 2000 Sep; 29(3):205-16. PubMed ID: 10996423 [TBL] [Abstract][Full Text] [Related]
10. Phase II trial of a 75-mg/m2 dose of docetaxel with prednisone premedication for patients with advanced non-small cell lung cancer. Miller VA; Rigas JR; Francis PA; Grant SC; Pisters KM; Venkatraman ES; Woolley K; Heelan RT; Kris MG Cancer; 1995 Feb; 75(4):968-72. PubMed ID: 7842417 [TBL] [Abstract][Full Text] [Related]
11. A phase II trial of docetaxel in advanced non-small cell lung cancer. Saarinen A; Jekunen A; Halme M; Pyrhönen S; Tamminen K; Boyer R; Roubille N; Mattson K Anticancer Drugs; 1996 Nov; 7(8):890-2. PubMed ID: 8991195 [TBL] [Abstract][Full Text] [Related]
12. Phase II trial of docetaxel in patients with stage III and IV non-small-cell lung cancer. Francis PA; Rigas JR; Kris MG; Pisters KM; Orazem JP; Woolley KJ; Heelan RT J Clin Oncol; 1994 Jun; 12(6):1232-7. PubMed ID: 7911159 [TBL] [Abstract][Full Text] [Related]
13. A phase II study of single-agent docetaxel chemotherapy for non-small cell lung cancer. Perng RP; Shih JF; Chen YM; Chou KC; Lee YC; Tsai CM Jpn J Clin Oncol; 2000 Oct; 30(10):429-34. PubMed ID: 11185888 [TBL] [Abstract][Full Text] [Related]
14. Docetaxel: a review of its use in non-small cell lung cancer. Comer AM; Goa KL Drugs Aging; 2000 Jul; 17(1):53-80. PubMed ID: 10933515 [TBL] [Abstract][Full Text] [Related]
15. Phase II trial of docetaxel in previously untreated advanced non-small-cell lung cancer: a Japanese cooperative study. Kunitoh H; Watanabe K; Onoshi T; Furuse K; Niitani H; Taguchi T J Clin Oncol; 1996 May; 14(5):1649-55. PubMed ID: 8622084 [TBL] [Abstract][Full Text] [Related]
16. Japanese experience with second-line chemotherapy with low-dose (60 mg/M2) docetaxel in patients with advanced non-small-cell lung cancer. Mukohara T; Takeda K; Miyazaki M; Takifuji N; Terakawa K; Negoro S Cancer Chemother Pharmacol; 2001 Nov; 48(5):356-60. PubMed ID: 11761452 [TBL] [Abstract][Full Text] [Related]
17. Phase II trial of docetaxel in Asian patients with inoperable stage III non-small cell lung cancer. Goh BC; Lehnert M; Lim HL; Ng AW; Chan CC; Kong HL; Lee SC; Wee J; Chua ET; Wong JE Acta Oncol; 2000; 39(2):225-9. PubMed ID: 10859016 [TBL] [Abstract][Full Text] [Related]
18. Phase II trial of weekly docetaxel in second-line therapy for nonsmall cell lung carcinoma. Lilenbaum RC; Schwartz MA; Seigel L; Belette F; Blaustein A; Wittlin FN; Davila E Cancer; 2001 Oct; 92(8):2158-63. PubMed ID: 11596033 [TBL] [Abstract][Full Text] [Related]
19. Pilot study of sequential vinorelbine and cisplatin followed by docetaxel for selected IIIB and stage IV non-small cell lung cancer. Clark JI; Kancharla K; Qamar R; Fisher S; Hantel A; Panganiban J; Millbrandt L; Albain KS Lung Cancer; 2001 Nov; 34(2):271-7. PubMed ID: 11679186 [TBL] [Abstract][Full Text] [Related]
20. Weekly chemotherapy with carboplatin, docetaxel and irinotecan in advanced non-small-cell-lung cancer: a phase II study. Pectasides D; Visvikis A; Kouloubinis A; Glotsos J; Bountouroglou N; Karvounis N; Ziras N; Athanassiou A Eur J Cancer; 2002 Jun; 38(9):1194-200. PubMed ID: 12044505 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]